Biosecurity Market By Product Type (Biocides & Disinfectants, Personal Protective Equipment (PPE), Detection & Monitoring Equipment, Decontamination Systems, and Others), by Application (Agriculture, Healthcare, Food Industry, Defense & Military, and Others), By End-User (Government & Regulatory Bodies, Healthcare Institutions, Agricultural Sector, Research & Academia, and Private & Commercial Sectors), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2025-2034

Report Overview

The Biosecurity Market Size is expected to be worth around US$ 40.93 billion by 2034 from US$ 17.45 billion in 2024, growing at a CAGR of 8.9% during the forecast period 2025 to 2034.

The biosecurity market plays a crucial role in safeguarding human, animal, and environmental health from the risk of biological threats, including infectious diseases, pests, and pathogens. It is driven by increasing concerns over public health safety, the need for food security, and the rising threats of bioterrorism and biological warfare. As global awareness of these risks grows, governments, healthcare providers, and industries are increasingly investing in biosecurity solutions to mitigate potential outbreaks and environmental hazards.

Biosecurity measures are employed across various sectors, including agriculture, healthcare, food safety, and defense. In agriculture, biosecurity focuses on protecting crops and livestock from diseases and pests that can have devastating economic and ecological consequences. Healthcare facilities use biosecurity practices to prevent the spread of infectious diseases, especially in hospitals and laboratories. The defense sector is also a key area, with biosecurity solutions aimed at protecting military personnel from biological warfare agents.

Technological advancements, such as biosensors, monitoring systems, and decontamination equipment, are enhancing biosecurity capabilities. Furthermore, regulations and standards, including those set by the World Health Organization (WHO) and national health authorities, are shaping the market by enforcing stringent biosecurity protocols. The market is expected to grow steadily due to the increasing need for advanced protection and prevention measures, particularly in response to emerging biological threats and global health challenges.

In March 2024, following U.S. Secretary of Agriculture Brooke Rollins’ recent announcement of emergency funding aimed at combating avian flu and reducing egg prices, the USDA is now expanding biosecurity assessments and audits for commercial poultry producers. These initiatives are part of proactive efforts to enhance biosecurity on individual farms and prevent the introduction or spread of highly pathogenic avian influenza (HPAI), providing direct support to America’s farmers and ranchers.

Key Takeaways

• In 2024, the market for Biosecurity generated a revenue of US$ 45 billion, with a CAGR of 8.9%, and is expected to reach US$ 40.93 billion by the year 2034.
• The product type segment is divided into Biocides & Disinfectants, Personal Protective Equipment (PPE), Detection & Monitoring Equipment, Decontamination Systems, and Others with Biocides & Disinfectants taking the lead in 2023 with a market share of 32.4%.
• By Application, the market is bifurcated into Agriculture, Healthcare, Food Industry, Defense & Military, and Others, with Agriculture leading the market with 30.2% of market share.
• Furthermore, concerning the End-User segment, the Government & Regulatory Bodies sector stands out as the dominant segment, holding the largest revenue share of 30.0% in the Biosecurity market.
• North America led the market by securing a market share of 41.2% in 2023.

Product Type Analysis

The biosecurity market can be segmented by product type into Biocides & Disinfectants, Personal Protective Equipment (PPE), Detection & Monitoring Equipment, Decontamination Systems, and Others. Biocides & Disinfectants lead the market with 32.4% market share due to their broad and consistent demand in various sectors. These products, which include chemicals designed to eliminate bacteria, viruses, and fungi, are widely used across various sectors, including healthcare, agriculture, and food safety.

In healthcare, disinfectants are used to clean hospital surfaces, medical equipment, and personal protective gear to reduce infection risks. In agriculture, they are applied to prevent the spread of plant diseases and pests, ensuring crop protection. The global demand for biocides and disinfectants has surged with increasing concerns over public health safety, particularly in response to disease outbreaks like COVID-19.

In June 2023, Minnesota-based conglomerate 3M has announced plans to invest $146 million to enhance its filtration technology in support of biopharmaceutical drug production. The investment will fund facility and equipment upgrades, along with the creation of 60 new jobs at the company’s plants in Europe. These improvements aim to accelerate 3M’s development and delivery of essential filtration equipment for bioprocessing, as well as for the manufacturing of biological and small molecule pharmaceuticals.

Application Analysis

The Agriculture segment dominates with 30.2% market share, driven by the need to protect crops and livestock from diseases, pests, and other biological threats. Agriculture has become increasingly reliant on biosecurity measures to prevent the spread of harmful pathogens that can devastate entire industries. Biocides, disinfectants, and monitoring systems are widely used to safeguard crops and prevent the spread of diseases like foot-and-mouth disease, avian flu, and various plant pathogens. This segment is essential for maintaining food security and ensuring the sustainability of agricultural practices.

As global food demand rises, the need for effective biosecurity solutions in agriculture continues to dominate the market. The Healthcare segment is another significant driver of the biosecurity market. The growing importance of infection control in healthcare settings, particularly in hospitals and laboratories, has resulted in increased demand for biosecurity solutions. Personal protective equipment (PPE), biocides, and disinfectants are vital to maintaining safe environments and preventing the spread of infectious diseases.

In December 2021, Neogen Corporation announced that it has entered into a definitive agreement with 3M, under which 3M will divest its Food Safety business and merge it with Neogen in a transaction structured to be tax-efficient for both 3M and its shareholders under U.S. federal income tax laws. This merger will form an innovative leader in the food safety industry, offering a broad product portfolio and a strategic emphasis on long-term growth opportunities in the sector.

End-User Analysis

The Government & Regulatory Bodies segment is the leading end-user in the biosecurity market with 30.0% market share, as governments worldwide play a crucial role in enforcing biosecurity regulations and ensuring the safety of public health and the environment. These bodies set the standards and policies that guide the use of biosecurity solutions across various sectors, including healthcare, agriculture, and defense.

Government agencies are responsible for monitoring biological threats, implementing quarantine measures, and overseeing the deployment of biosecurity products to prevent disease outbreaks and bioterrorism. As biological risks and public health concerns increase globally, this segment maintains a dominant position in driving the demand for biosecurity solutions.

The Healthcare Institutions segment is a key player in the biosecurity market, driven by the need for infection control and the protection of patients and healthcare workers. Hospitals, clinics, and laboratories require biosecurity measures such as PPE, biocides, and disinfectants to prevent the spread of infectious diseases.

Key Market Segments

By Product Type

• Biocides & Disinfectants
• Personal Protective Equipment (PPE)
• Detection & Monitoring Equipment
• Decontamination Systems
• Others

By Application

• Agriculture
• Healthcare
• Food Industry
• Defense & Military
• Others

By End-User

• Government & Regulatory Bodies
• Healthcare Institutions
• Agricultural Sector
• Research & Academia
• Private & Commercial Sectors

Drivers

Increasing Global Health Threats

The growing threat of infectious diseases, pandemics, and bioterrorism is a key driver of the biosecurity market. As the world faces an increase in health crises, including the rise of zoonotic diseases, antimicrobial resistance, and bioterrorism threats, the demand for biosecurity solutions has significantly heightened. The COVID-19 pandemic highlighted the urgent need for robust biosecurity measures in healthcare settings, agriculture, and public spaces.

In agriculture, the spread of plant and animal diseases poses a major risk to global food security, prompting governments and agricultural businesses to invest in biosecurity technologies such as monitoring systems, biocides, and protective equipment. Similarly, in healthcare, infection control and the prevention of disease outbreaks drive the adoption of personal protective equipment (PPE), disinfectants, and decontamination systems. The increasing frequency of disease outbreaks globally amplifies the need for advanced biosecurity solutions to protect public health, food supplies, and the economy, further fueling the market growth.

Restraints

High Costs of Biosecurity Measures

A major restraint in the biosecurity market is the high cost associated with the implementation of comprehensive biosecurity measures. The purchase of advanced equipment, such as decontamination systems, detection devices, and monitoring technologies, can be costly for organizations, especially small businesses and farms. Additionally, the ongoing maintenance and training required for personnel to properly use and manage these biosecurity solutions add to the financial burden.

In healthcare institutions and agricultural sectors, the need for specialized biosecurity measures, including regular cleaning, testing, and monitoring, can strain budgets. While large organizations can absorb these costs, smaller players may face challenges in investing in the necessary infrastructure to comply with biosecurity regulations. Furthermore, in regions with less funding for public health or agricultural sectors, the cost barrier can slow the adoption of essential biosecurity measures, limiting the market’s potential growth.

Opportunities

Technological Advancements in Detection and Monitoring

An exciting opportunity in the biosecurity market lies in the advancement of detection and monitoring technologies. The growing adoption of artificial intelligence (AI), biosensors, and Internet of Things (IoT)-enabled devices presents a significant opportunity to enhance biosecurity measures across industries. Real-time monitoring and detection systems can provide immediate alerts regarding biological threats, such as pathogens or contaminants, allowing for quicker responses and reducing the spread of diseases.

In agriculture, these technologies can be used for early detection of plant and animal diseases, helping farmers protect crops and livestock before an outbreak occurs. In healthcare, smart biosensors and surveillance systems can be implemented to track infection rates, identify contamination in medical settings, and improve patient safety. As these technologies evolve and become more cost-effective, their adoption is expected to increase, offering a substantial growth opportunity in the biosecurity market. Companies that can innovate in this space are well-positioned to drive advancements and capture a larger share of the market.

Impact of Macroeconomic / Geopolitical Factors

Macroeconomic and geopolitical factors significantly impact the biosecurity market, influencing both demand and supply dynamics. Economic downturns can constrain budgets for healthcare and agricultural sectors, potentially limiting investment in biosecurity solutions. However, heightened awareness of global health risks, such as pandemics, can prompt governments and organizations to prioritize biosecurity spending, mitigating the economic challenges.

Geopolitical tensions and trade conflicts can disrupt supply chains, affecting the availability of critical biosecurity products, particularly those sourced from international suppliers. For instance, tariff impositions or trade sanctions may hinder the flow of disinfectants, protective equipment, or detection technologies.

Additionally, political instability in regions with vulnerable healthcare infrastructure can exacerbate the risk of disease outbreaks, creating urgent demand for biosecurity measures. On the positive side, international collaborations and government funding programs to address biosecurity threats, such as bioterrorism or infectious diseases, can provide opportunities for market expansion, encouraging investments in new technologies and solutions.

Latest Trends

Increasing Adoption of Automation and Robotics

A notable trend in the biosecurity market is the increasing adoption of automation and robotics, particularly in industries like agriculture and healthcare. Automated systems, such as robotic disinfectants and drones equipped with sensors, are becoming more prevalent in maintaining biosecurity standards. In healthcare settings, robotic systems are used for disinfecting patient rooms, cleaning medical equipment, and ensuring sterile environments in operating rooms. This not only improves efficiency but also minimizes human error and reduces the risk of contamination.

In agriculture, autonomous vehicles and drones are being employed to monitor crops and livestock, applying pesticides or disinfectants in a controlled, precise manner. Automation is enhancing the effectiveness and scalability of biosecurity solutions, enabling large-scale operations to maintain high levels of hygiene and safety. This trend toward automation is driven by advancements in robotics, AI, and machine learning, and it is expected to continue to grow, further transforming the biosecurity landscape across industries.

In June 2020, OSI Systems, Inc. announced that its Security division has been awarded a contract valued at approximately $5 million by the Commonwealth Government of Australia, represented by the Department of Agriculture, Water and the Environment (DAWE). The contract includes the supply of Rapiscan RTT110 hold baggage screening systems and the development and delivery of software algorithms designed for the automated detection of biosecurity risk items.

Regional Analysis

North America is leading the Biosecurity Market

The biosecurity market in North America is poised for significant growth, driven by increasing concerns over public health, agriculture, and national security. The United States and Canada are major contributors to the market, with robust regulatory frameworks that enforce stringent biosecurity protocols across sectors like healthcare, agriculture, and defense. In healthcare, the COVID-19 pandemic heightened the demand for personal protective equipment (PPE), disinfectants, and infection control measures, which continue to be critical in hospitals and clinics.

In agriculture, North America invests heavily in biosecurity solutions to protect crops and livestock from diseases and pests, ensuring food safety and security. The region’s strong government presence, including agencies like the CDC and USDA, plays a vital role in shaping biosecurity policies. Furthermore, increasing investments in advanced detection systems, decontamination technologies, and monitoring tools are expected to drive continued market growth. North America’s focus on innovation and regulatory enforcement positions it as a dominant region in the global biosecurity market.

Key Regions and Countries

• North America
  • US
  • Canada
• Europe
  • Germany
  • France
  • The UK
  • Spain
  • Italy
  • Russia
  • Netherland
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • South Korea
  • India
  • Australia
  • New Zealand
  • Singapore
  • Thailand
  • Vietnam
  • Rest of APAC
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of MEA

Key Players Analysis

Key Players in the Biosecurity market includes 3M Company, BASF SE, DuPont de Nemours, Inc., Thermo Fisher Scientific Inc., EnviroTech Services, Inc., Lonza Group Ltd., Tetra Tech, Inc., Bayer AG, Ecolab Inc., Johns Hopkins University Applied Physics Laboratory, Agilent Technologies, Inc., Vetoquinol S.A., Merck & Co., Inc., Zymergen Inc., SAB Biotherapeutics, Inc., Scalable Solutions LLC, Schering-Plough Corporation (now part of Merck), Biochem Laboratories, Inc., Oxitec Ltd., Bio-Rad Laboratories, Inc., Inovio Pharmaceuticals, and Inc.

3M Company is a key player in the biosecurity market, offering a broad range of products designed to protect public health and safety across industries such as healthcare, defense, and agriculture. In the biosecurity sector, 3M is recognized for its development of personal protective equipment (PPE), including respirators, face shields, and gloves, which are crucial in preventing the spread of infectious diseases.

BASF SE, a global chemical company, contributes significantly to the biosecurity market through its production of biocides, disinfectants, and pest control solutions. DuPont de Nemours, Inc. is a prominent player in the biosecurity market, offering advanced solutions in PPE, filtration systems, and decontamination products. The company’s biosecurity products are used across various sectors, including healthcare, agriculture, and industrial applications.

Top Key Players in the Biosecurity Market

• 3M Company
• BASF SE
• DuPont de Nemours, Inc.
• Thermo Fisher Scientific Inc.
• EnviroTech Services, Inc.
• Lonza Group Ltd.
• Tetra Tech, Inc.
• Bayer AG
• Ecolab Inc.
• Johns Hopkins University Applied Physics Laboratory
• Agilent Technologies, Inc.
• Vetoquinol S.A.
• Merck & Co., Inc.
• Zymergen Inc.
• SAB Biotherapeutics, Inc.
• Scalable Solutions LLC
• Schering-Plough Corporation (now part of Merck)
• Biochem Laboratories, Inc.
• Oxitec Ltd.
• Bio-Rad Laboratories, Inc.
• Inovio Pharmaceuticals, Inc.
• Other Prominent Players

Recent Developments

• In July 2024: The Bipartisan Commission on Biodefense introduced B-SPAN, an innovative interactive tool that highlights the segments of both the executive and legislative branches of government dedicated to biodefense.
• In March 2024: Emergent BioSolutions Inc. (EBS) received approval from the U.S. Food and Drug Administration (FDA) for BioThrax, for both pre-exposure and post-exposure prophylaxis of anthrax.
• In March 2024: Bavarian Nordic gained approval from the Swiss Agency for Therapeutic Products, Swissmedic, for JYNNEOS (MVA-BN), for the active immunization of adults aged 18 and older against diseases caused by smallpox, mpox, and vaccinia viruses.

Report Scope